While previous studies on IFN and SARS-CoV-2 have focused on Type I IFN due to their robust capacity to interfere with viral replication43, several studies have indicated that IFN-γ is also an essential component in the severity of COVID-19 (refs. 29,44,45). The gene discussed is IFNA1; the disease is COVID-19.